Lactate dehydrogenase/albumin ratio as a prognostic factor in severe acute respiratory distress syndrome cases associated with COVID-19Article Published on 2022-09-232022-11-15 Journal: Medicine [Category] 바이오마커, [키워드] acute respiratory distress Admission affected affecting Analysis ARDS AUC Biomarker C-reactive protein calculated can be used caused characteristic Clinical characteristics confidence interval COVID 19 COVID-19 COVID-19 diagnosis determine early stages evaluated Factors FIVE high mortality hospital ICU in-hospital mortality independent independent risk factor intensive care laboratory result lactate dehydrogenase LDH lung damage marker Mortality mortality rate multivariate logistic regression Patient patients hospitalized predict predicted Prognosis prognostic biomarker Prognostic factor regression analysis severe ARDS syndrome Tertiary the patient was performed were recorded with COVID-19 [DOI] 10.1097/MD.0000000000030759 PMC 바로가기
Immune-inflammatory biomarkers and the risk of cardiac injury in COVID-19 patients with diabetes: a retrospective cohort studyArticle Published on 2022-09-192022-11-15 Journal: Cardiovascular Diabetology [Category] 바이오마커, 진단, [키워드] 95% CI 95% confidence interval adjusted age Biomarker cardiac cardiac injury CD3 CD4 Clinical data collected Concentration conducted COVID-19 COVID-19 patient COVID-19 patients demographic data determine Diabetes Mellitus Diabetic diabetic patient diagnosed expected Gender Glucose high risk IgA IL-6 Immune-inflammatory biomarkers immunoglobulin A in-hospital mortality incidence independent risk factor induce Injury Inpatient Interaction interleukin-6 logistics Mortality myocardial damage outcomes parameter participant Patient plasma predictor regression analysis Renmin Hospital responses retrospective cohort study Retrospective study risk T cell university were assessed with COVID-19 Wuhan [DOI] 10.1186/s12933-022-01625-2 PMC 바로가기
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods – United States, April 2020-June 2022Article Published on 2022-09-162022-11-16 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, [키워드] adjusted age calculated cause CDC Clinical characteristics COVID-19 COVID-19 hospitalization database deaths Delta early treatment Ethnic groups females Health authority hospital hospitalized COVID-19 patient hospitalized patients In-hospital death in-hospital mortality increase indicated lower mortality male medical condition Medical conditions Mortality mortality risk nonpharmaceutical intervention occurred omicron pandemic Patient patients hospitalized Period proportion public health Racial reported risk United States variant variant of SARS-CoV-2 virus [DOI] 10.15585/mmwr.mm7137a4 PMC 바로가기
Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: results from the SEMI-COVID-19 registryObservational Study Published on 2022-09-092022-10-04 Journal: Medicina clínica [Category] SARS, 임상, [키워드] Admission Analysis analyzed Charlson index Clinical characteristics coronavirus disease Course COVID-19 difference discharge events Evolution group hospital Hospitalizado Hospitalized ICU ICU admission in-hospital mortality Inconclusive independent influence intensive care male males median age Mortalidad Mortality multicenter multivariate logistic regression Older Patient patients patients with COVID-19 poor prognosis positive Prevalence previous study readmission remained retrospective cohort study SARS-CoV-2 SARS-COV-2 infection severity Smokers smoking Spanish Tabaquismo. the disease the patient were recorded [DOI] 10.1016/j.medcli.2021.10.011 PMC 바로가기 [Article Type] Observational Study
Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 PatientsArticle Published on 2022-09-092022-11-15 Journal: International Journal of Molecular Sciences [Category] 바이오마커, [키워드] Analysis AST calculated Clinical course contribute COVID-19 COVID-19 pandemic creatinine Critical critical COVID-19 patients CRP cut-off demonstrated diagnosed with COVID-19 global healthcare groups healthcare identify IL-6 in-hospital mortality in-hospital mortality rate Inflammation Inflammatory biomarker inflammatory parameter INR Kaplan-Meier survival curve laboratory parameter marker Mortality non-survivor parameter Patient patients performed Predictive prognostic reducing retrospective risk stratification ROC significantly higher statistical analysis statistically significant statistically significant difference survival survivor thresholds urea WBC [DOI] 10.3390/ijms231810423 PMC 바로가기
The prognostic value of biomarker levels and chest imaging in patients with COVID-19 presenting to the emergency department응급실에 제출하는 COVID-19 환자의 바이오마커 수치 및 흉부 영상의 예후 가치Article Published on 2022-09-012022-09-11 Journal: The American journal of emergency medicine [Category] COVID19(2023년), MERS, SARS, 바이오마커, [키워드] 95% CI age AUC Biomarker Biomarkers C-reactive protein Care Chain Reaction Chest CT chest imaging COVID-19 COVID-19 patient COVID-19 patients CRP D-dimer Department dimer Emergency emergency department ferritin Hospital mortality ICU admission in-hospital mortality Laboratory parameters Lactate lactate dehydrogenase LDH Logistic regression Lung imaging lymphocyte mechanical ventilation Mortality Natriuretic neutrophil Neutrophil to lymphocyte ratio neutrophil/lymphocyte ratio NLR not performed obesity Patient patients with COVID-19 peptide performed polymerase chain polymerase chain reaction positive presenting Primary outcome procalcitonin prognostic Prognostic value Quantitative real-time reverse transcriptase retrospective reverse transcriptase Reverse transcriptase polymerase chain reaction severity significantly tested troponin vital sign [DOI] 10.1016/j.ajem.2022.06.043 PMC 바로가기 [Article Type] Article
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched StudyMulticenter Study Published on 2022-09-012023-07-08 Journal: Journal of Intensive Care Medicine [Category] COVID19(2023년), [키워드] 30-Day mortality Aspirin COVID-19 Critically ill in-hospital mortality intensive care units (ICUs). SARS-CoV-2 [DOI] 10.1177/08850666221093229 PMC 바로가기 [Article Type] Multicenter Study
The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort studyMulticenter Study Published on 2022-09-012022-10-05 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 바이오마커, 진단, [키워드] 1:1 95% CI benefit cohort study Complication Confirmed COVID-19 infection COVID-19 criteria Critically ill Critically ill patient Effectiveness elderly evaluate ICU ICUs in-hospital mortality intensive care unit mechanical ventilation Mortality multicenter objective Older older adult P-value Patient patients with COVID-19 Primary outcome Propensity score Respiratory failure Result Retrospective study safety profile SARS-CoV-2 selected severe COVID-19 statistically significant difference Support TCZ Tocilizumab two group Ventilator-free days was used with COVID-19 [DOI] 10.1016/j.ijid.2022.05.038 [Article Type] Multicenter Study
Prognostic value of the TyG index for in-hospital mortality in nondiabetic COVID-19 patients with myocardial injuryArticle Published on 2022-09-012022-11-15 Journal: Revista da Associação Médica Brasileira (1992) [Category] 바이오마커, [키워드] Analysis blood glucose characteristic coronavirus disease COVID-19 COVID-19 patient cutoff value demonstrated Efficacy fasting blood Glucose greater Hospitalization identify In-hospital death in-hospital mortality log multivariate Cox regression myocardial damage myocardial injury Patient patients patients died predicted Retrospective study ROC sensitivity specificity Survivors Triglyceride [DOI] 10.1590/1806-9282.20220410 PMC 바로가기
Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort StudyArticle Published on 2022-09-012022-11-15 Journal: Clinical drug investigation [Category] SARS, 치료제, [키워드] administration age analyzed antiviral drug blockers bradycardia bradycardic cardiac complication cardiac effect cause Characteristics clinical Clinical characteristics Cohort conducted coronavirus disease COVID-19 COVID-19 patient D-dimer level elimination half-life Endotracheal intubation examined excluded Frame Future hyperlipidemia in-hospital mortality inclusion criteria initiated investigated Mortality occur outcomes Patient predictor previous study Remdesivir reported Retrospective study serum Sex significant difference significantly more statistical test treat Treatment undergo [DOI] 10.1007/s40261-022-01187-x PMC 바로가기